Most Recent
Hytera ordered to hand over source code in Motorola IP dispute
Herbert Smith Freehills 2018-08-30 9:41 pm By Miklos Bolza Sydney

Chinese tech company Hytera Communications Corporation has been ordered to hand over source code for all radio devices at the heart of a international patent dispute with Motorola Solutions.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Alphapharm says Sanofi patent amendment should doom injunction bid
Christian Dimitriadis 2018-08-30 9:13 pm By Miklos Bolza Sydney

Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the proposed injunction should be denied because Sanofi is seeking to amend the patent at issue.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Fonterra denied strict confidentiality regime in Bega trade mark dispute
Albert Ounapuu 2018-08-29 9:33 pm By Cat Fredenburgh Melbourne

A judge has denied a bid for a strict regime for dealing with confidential information in a lawsuit between cheese giants Fonterra and Bega over alleged violations of the terms of a trade mark licensing agreement.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Apotex threatened to infringe Cialis patents, court finds
Healthcare 2018-08-27 11:09 pm By Cat Fredenburgh Melbourne

A judge has found two patents held by an Eli Lilly & Co. unit for erectile dysfunction drug Cialis are valid and that generic manufacturer Apotex threatened to infringe the patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Millennium wins injunction against Juno over generic cancer drug
Biopharmalex 2018-08-27 11:27 am By Christine Caulfield Melbourne

US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
Biopharmalex 2018-08-23 5:41 pm By Miklos Bolza Sydney

An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Guard rail maker wins ruling invalidating rival’s patent
Intellectual Property 2018-08-22 11:34 pm By Cat Fredenburgh

A maker of guard rails used on highways has won a judgment invalidating a rival’s patent, with a judge finding the patent lacks novelty.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Kraft can bring new claims against Bega mid-trial
Addisons 2018-08-22 8:00 pm By Cat Fredenburgh Melbourne

The long, complex battle over who owns the rights to the Kraft peanut butter trade dress just promised to get longer, with Kraft winning approval to bring fresh allegations against Bega mid-trial.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sanofi launches patent case over Alphapharm injector pen
Healthcare 2018-08-21 11:00 pm By Miklos Bolza Sydney

Global pharmaceutical giant Sanofi-Aventis has launched patent infringement proceedings against generic drug maker Alphapharm seeking “urgent interlocutory relief” to prevent a generic injector pen from being listed on the market.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Apple keeps patent application for iPhone, iPad interface alive
Article 2018-08-21 10:46 pm By Cat Fredenburgh Melbourne

A patent application for a computer-implemented invention filed by Apple may have a shot at approval, with a delegate for IP Australia saying strict tests for patentability should be eschewed in favor of a more holistic approach.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?